Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Share-based Compensation (2016 - 2026)

Healthequity (HQY) has 13 years of Share-based Compensation data on record, last reported at $20.5 million in Q4 2025.

  • For Q4 2025, Share-based Compensation fell 2.75% year-over-year to $20.5 million; the TTM value through Oct 2025 reached $75.7 million, down 17.7%, while the annual FY2025 figure was $96.4 million, 24.98% up from the prior year.
  • Share-based Compensation reached $20.5 million in Q4 2025 per HQY's latest filing, up from $19.1 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $32.0 million in Q2 2024 and bottomed at $11.0 million in Q1 2022.
  • Average Share-based Compensation over 5 years is $17.8 million, with a median of $18.2 million recorded in 2022.
  • Peak YoY movement for Share-based Compensation: skyrocketed 75.9% in 2024, then plummeted 55.23% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $13.3 million in 2021, then surged by 36.78% to $18.2 million in 2022, then grew by 19.22% to $21.7 million in 2023, then fell by 2.49% to $21.1 million in 2024, then fell by 2.75% to $20.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Share-based Compensation were $20.5 million in Q4 2025, $19.1 million in Q3 2025, and $14.3 million in Q2 2025.